nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2C8—Paclitaxel—ovarian cancer	0.112	0.167	CbGbCtD
Carbinoxamine—CYP2D6—Vinorelbine—ovarian cancer	0.101	0.152	CbGbCtD
Carbinoxamine—CYP3A4—Topotecan—ovarian cancer	0.0916	0.137	CbGbCtD
Carbinoxamine—CYP2B6—Doxorubicin—ovarian cancer	0.0796	0.119	CbGbCtD
Carbinoxamine—CYP2C9—Paclitaxel—ovarian cancer	0.078	0.117	CbGbCtD
Carbinoxamine—CYP3A4—Vinorelbine—ovarian cancer	0.0645	0.0966	CbGbCtD
Carbinoxamine—CYP3A4—Paclitaxel—ovarian cancer	0.0453	0.0679	CbGbCtD
Carbinoxamine—CYP2D6—Doxorubicin—ovarian cancer	0.0384	0.0575	CbGbCtD
Carbinoxamine—CYP3A4—Docetaxel—ovarian cancer	0.0328	0.0491	CbGbCtD
Carbinoxamine—CYP3A4—Doxorubicin—ovarian cancer	0.0244	0.0366	CbGbCtD
Carbinoxamine—Neuropathy peripheral—Altretamine—ovarian cancer	0.0092	0.0277	CcSEcCtD
Carbinoxamine—Neuritis—Chlorambucil—ovarian cancer	0.00799	0.0241	CcSEcCtD
Carbinoxamine—Vertigo—Altretamine—ovarian cancer	0.00659	0.0199	CcSEcCtD
Carbinoxamine—Convulsion—Altretamine—ovarian cancer	0.00636	0.0191	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Altretamine—ovarian cancer	0.00586	0.0177	CcSEcCtD
Carbinoxamine—Anorexia—Altretamine—ovarian cancer	0.00571	0.0172	CcSEcCtD
Carbinoxamine—Chest tightness—Docetaxel—ovarian cancer	0.00552	0.0166	CcSEcCtD
Carbinoxamine—Decreased appetite—Altretamine—ovarian cancer	0.0052	0.0157	CcSEcCtD
Carbinoxamine—Fatigue—Altretamine—ovarian cancer	0.00516	0.0155	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Chlorambucil—ovarian cancer	0.0048	0.0144	CcSEcCtD
Carbinoxamine—Asthenia—Altretamine—ovarian cancer	0.0043	0.0129	CcSEcCtD
Carbinoxamine—Haemolytic anaemia—Melphalan—ovarian cancer	0.00418	0.0126	CcSEcCtD
Carbinoxamine—Neuritis—Paclitaxel—ovarian cancer	0.00409	0.0123	CcSEcCtD
Carbinoxamine—Dizziness—Altretamine—ovarian cancer	0.00396	0.0119	CcSEcCtD
Carbinoxamine—Vomiting—Altretamine—ovarian cancer	0.00381	0.0115	CcSEcCtD
Carbinoxamine—Extrasystoles—Paclitaxel—ovarian cancer	0.00363	0.0109	CcSEcCtD
Carbinoxamine—Nausea—Altretamine—ovarian cancer	0.00356	0.0107	CcSEcCtD
Carbinoxamine—Neuritis—Docetaxel—ovarian cancer	0.00347	0.0104	CcSEcCtD
Carbinoxamine—Chest discomfort—Paclitaxel—ovarian cancer	0.00345	0.0104	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Chlorambucil—ovarian cancer	0.00327	0.00985	CcSEcCtD
Carbinoxamine—Wheezing—Paclitaxel—ovarian cancer	0.00297	0.00894	CcSEcCtD
Carbinoxamine—Chest discomfort—Docetaxel—ovarian cancer	0.00293	0.00882	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Topotecan—ovarian cancer	0.00291	0.00877	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Melphalan—ovarian cancer	0.00285	0.00859	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Vinorelbine—ovarian cancer	0.00249	0.0075	CcSEcCtD
Carbinoxamine—Tremor—Chlorambucil—ovarian cancer	0.00244	0.00736	CcSEcCtD
Carbinoxamine—Nasal congestion—Paclitaxel—ovarian cancer	0.00243	0.00733	CcSEcCtD
Carbinoxamine—Agitation—Chlorambucil—ovarian cancer	0.0024	0.00722	CcSEcCtD
Carbinoxamine—Chills—Topotecan—ovarian cancer	0.00239	0.00721	CcSEcCtD
Carbinoxamine—Agranulocytosis—Vinorelbine—ovarian cancer	0.00237	0.00714	CcSEcCtD
Carbinoxamine—Neuritis—Epirubicin—ovarian cancer	0.00234	0.00705	CcSEcCtD
Carbinoxamine—Convulsion—Chlorambucil—ovarian cancer	0.00226	0.0068	CcSEcCtD
Carbinoxamine—Neuritis—Doxorubicin—ovarian cancer	0.00216	0.00652	CcSEcCtD
Carbinoxamine—Confusional state—Chlorambucil—ovarian cancer	0.00215	0.00646	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Chlorambucil—ovarian cancer	0.00208	0.00628	CcSEcCtD
Carbinoxamine—Anorexia—Chlorambucil—ovarian cancer	0.00203	0.00611	CcSEcCtD
Carbinoxamine—Convulsion—Melphalan—ovarian cancer	0.00197	0.00593	CcSEcCtD
Carbinoxamine—Dyspepsia—Chlorambucil—ovarian cancer	0.00187	0.00564	CcSEcCtD
Carbinoxamine—Sweating increased—Paclitaxel—ovarian cancer	0.00187	0.00562	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Topotecan—ovarian cancer	0.00185	0.00559	CcSEcCtD
Carbinoxamine—Decreased appetite—Chlorambucil—ovarian cancer	0.00185	0.00557	CcSEcCtD
Carbinoxamine—Fatigue—Chlorambucil—ovarian cancer	0.00183	0.00553	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Topotecan—ovarian cancer	0.00183	0.00552	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Melphalan—ovarian cancer	0.00182	0.00547	CcSEcCtD
Carbinoxamine—Tachycardia—Melphalan—ovarian cancer	0.00181	0.00545	CcSEcCtD
Carbinoxamine—Anorexia—Topotecan—ovarian cancer	0.00181	0.00544	CcSEcCtD
Carbinoxamine—Vertigo—Vinorelbine—ovarian cancer	0.00178	0.00537	CcSEcCtD
Carbinoxamine—Pollakiuria—Paclitaxel—ovarian cancer	0.00177	0.00533	CcSEcCtD
Carbinoxamine—Anorexia—Melphalan—ovarian cancer	0.00177	0.00533	CcSEcCtD
Carbinoxamine—Palpitations—Vinorelbine—ovarian cancer	0.00175	0.00529	CcSEcCtD
Carbinoxamine—Feeling abnormal—Chlorambucil—ovarian cancer	0.00175	0.00528	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Paclitaxel—ovarian cancer	0.00175	0.00527	CcSEcCtD
Carbinoxamine—Hypotension—Melphalan—ovarian cancer	0.00173	0.00522	CcSEcCtD
Carbinoxamine—Paraesthesia—Topotecan—ovarian cancer	0.0017	0.00512	CcSEcCtD
Carbinoxamine—Urticaria—Chlorambucil—ovarian cancer	0.00169	0.00509	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Paclitaxel—ovarian cancer	0.00168	0.00505	CcSEcCtD
Carbinoxamine—Dyspepsia—Topotecan—ovarian cancer	0.00167	0.00502	CcSEcCtD
Carbinoxamine—Paraesthesia—Melphalan—ovarian cancer	0.00167	0.00502	CcSEcCtD
Carbinoxamine—Decreased appetite—Topotecan—ovarian cancer	0.00165	0.00496	CcSEcCtD
Carbinoxamine—Fatigue—Topotecan—ovarian cancer	0.00163	0.00492	CcSEcCtD
Carbinoxamine—Dyspepsia—Melphalan—ovarian cancer	0.00163	0.00492	CcSEcCtD
Carbinoxamine—Constipation—Topotecan—ovarian cancer	0.00162	0.00488	CcSEcCtD
Carbinoxamine—Decreased appetite—Melphalan—ovarian cancer	0.00161	0.00486	CcSEcCtD
Carbinoxamine—Fatigue—Melphalan—ovarian cancer	0.0016	0.00482	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Vinorelbine—ovarian cancer	0.00159	0.00478	CcSEcCtD
Carbinoxamine—Tachycardia—Vinorelbine—ovarian cancer	0.00158	0.00476	CcSEcCtD
Carbinoxamine—Feeling abnormal—Topotecan—ovarian cancer	0.00156	0.0047	CcSEcCtD
Carbinoxamine—Anorexia—Vinorelbine—ovarian cancer	0.00154	0.00465	CcSEcCtD
Carbinoxamine—Asthenia—Chlorambucil—ovarian cancer	0.00153	0.0046	CcSEcCtD
Carbinoxamine—Hypotension—Vinorelbine—ovarian cancer	0.00151	0.00456	CcSEcCtD
Carbinoxamine—Urticaria—Topotecan—ovarian cancer	0.0015	0.00453	CcSEcCtD
Carbinoxamine—Urticaria—Melphalan—ovarian cancer	0.00147	0.00444	CcSEcCtD
Carbinoxamine—Diarrhoea—Chlorambucil—ovarian cancer	0.00146	0.00439	CcSEcCtD
Carbinoxamine—Paraesthesia—Vinorelbine—ovarian cancer	0.00146	0.00438	CcSEcCtD
Carbinoxamine—Photosensitivity—Epirubicin—ovarian cancer	0.00144	0.00435	CcSEcCtD
Carbinoxamine—Tinnitus—Paclitaxel—ovarian cancer	0.00143	0.00431	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Docetaxel—ovarian cancer	0.00142	0.00428	CcSEcCtD
Carbinoxamine—Decreased appetite—Vinorelbine—ovarian cancer	0.00141	0.00424	CcSEcCtD
Carbinoxamine—Fatigue—Vinorelbine—ovarian cancer	0.0014	0.00421	CcSEcCtD
Carbinoxamine—Constipation—Vinorelbine—ovarian cancer	0.00139	0.00417	CcSEcCtD
Carbinoxamine—Chills—Paclitaxel—ovarian cancer	0.00138	0.00415	CcSEcCtD
Carbinoxamine—Asthenia—Topotecan—ovarian cancer	0.00136	0.00409	CcSEcCtD
Carbinoxamine—Vomiting—Chlorambucil—ovarian cancer	0.00135	0.00408	CcSEcCtD
Carbinoxamine—Agranulocytosis—Docetaxel—ovarian cancer	0.00135	0.00407	CcSEcCtD
Carbinoxamine—Photosensitivity—Doxorubicin—ovarian cancer	0.00134	0.00402	CcSEcCtD
Carbinoxamine—Feeling abnormal—Vinorelbine—ovarian cancer	0.00134	0.00402	CcSEcCtD
Carbinoxamine—Asthenia—Melphalan—ovarian cancer	0.00133	0.00401	CcSEcCtD
Carbinoxamine—Tension—Paclitaxel—ovarian cancer	0.00131	0.00395	CcSEcCtD
Carbinoxamine—Nervousness—Paclitaxel—ovarian cancer	0.0013	0.00391	CcSEcCtD
Carbinoxamine—Diarrhoea—Topotecan—ovarian cancer	0.0013	0.0039	CcSEcCtD
Carbinoxamine—Urticaria—Vinorelbine—ovarian cancer	0.00129	0.00388	CcSEcCtD
Carbinoxamine—Diarrhoea—Melphalan—ovarian cancer	0.00127	0.00382	CcSEcCtD
Carbinoxamine—Diplopia—Epirubicin—ovarian cancer	0.00127	0.00382	CcSEcCtD
Carbinoxamine—Nausea—Chlorambucil—ovarian cancer	0.00126	0.00381	CcSEcCtD
Carbinoxamine—Vision blurred—Paclitaxel—ovarian cancer	0.00126	0.00379	CcSEcCtD
Carbinoxamine—Dizziness—Topotecan—ovarian cancer	0.00125	0.00377	CcSEcCtD
Carbinoxamine—Tremor—Paclitaxel—ovarian cancer	0.00125	0.00377	CcSEcCtD
Carbinoxamine—Agitation—Paclitaxel—ovarian cancer	0.00123	0.0037	CcSEcCtD
Carbinoxamine—Vomiting—Topotecan—ovarian cancer	0.0012	0.00363	CcSEcCtD
Carbinoxamine—Vertigo—Paclitaxel—ovarian cancer	0.0012	0.00361	CcSEcCtD
Carbinoxamine—Headache—Topotecan—ovarian cancer	0.00119	0.00357	CcSEcCtD
Carbinoxamine—Palpitations—Paclitaxel—ovarian cancer	0.00118	0.00355	CcSEcCtD
Carbinoxamine—Vomiting—Melphalan—ovarian cancer	0.00118	0.00355	CcSEcCtD
Carbinoxamine—Diplopia—Doxorubicin—ovarian cancer	0.00117	0.00353	CcSEcCtD
Carbinoxamine—Chills—Docetaxel—ovarian cancer	0.00117	0.00351	CcSEcCtD
Carbinoxamine—Asthenia—Vinorelbine—ovarian cancer	0.00116	0.0035	CcSEcCtD
Carbinoxamine—Convulsion—Paclitaxel—ovarian cancer	0.00116	0.00349	CcSEcCtD
Carbinoxamine—Nausea—Topotecan—ovarian cancer	0.00113	0.00339	CcSEcCtD
Carbinoxamine—Diarrhoea—Vinorelbine—ovarian cancer	0.00111	0.00334	CcSEcCtD
Carbinoxamine—Nausea—Melphalan—ovarian cancer	0.0011	0.00332	CcSEcCtD
Carbinoxamine—Confusional state—Paclitaxel—ovarian cancer	0.0011	0.00331	CcSEcCtD
Carbinoxamine—Dizziness—Vinorelbine—ovarian cancer	0.00107	0.00323	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.00107	0.00321	CcSEcCtD
Carbinoxamine—Tachycardia—Paclitaxel—ovarian cancer	0.00106	0.0032	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00105	0.00317	CcSEcCtD
Carbinoxamine—Anorexia—Paclitaxel—ovarian cancer	0.00104	0.00313	CcSEcCtD
Carbinoxamine—Vomiting—Vinorelbine—ovarian cancer	0.00103	0.0031	CcSEcCtD
Carbinoxamine—Hypotension—Paclitaxel—ovarian cancer	0.00102	0.00307	CcSEcCtD
Carbinoxamine—Headache—Vinorelbine—ovarian cancer	0.00102	0.00306	CcSEcCtD
Carbinoxamine—Pollakiuria—Epirubicin—ovarian cancer	0.00101	0.00305	CcSEcCtD
Carbinoxamine—Palpitations—Docetaxel—ovarian cancer	0.001	0.00301	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Epirubicin—ovarian cancer	0.001	0.00301	CcSEcCtD
Carbinoxamine—Insomnia—Paclitaxel—ovarian cancer	0.000986	0.00297	CcSEcCtD
Carbinoxamine—Convulsion—Docetaxel—ovarian cancer	0.000981	0.00295	CcSEcCtD
Carbinoxamine—Paraesthesia—Paclitaxel—ovarian cancer	0.000979	0.00295	CcSEcCtD
Carbinoxamine—Drowsiness—Epirubicin—ovarian cancer	0.000977	0.00294	CcSEcCtD
Carbinoxamine—Somnolence—Paclitaxel—ovarian cancer	0.000969	0.00292	CcSEcCtD
Carbinoxamine—Nausea—Vinorelbine—ovarian cancer	0.000962	0.0029	CcSEcCtD
Carbinoxamine—Dyspepsia—Paclitaxel—ovarian cancer	0.000959	0.00289	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000958	0.00288	CcSEcCtD
Carbinoxamine—Decreased appetite—Paclitaxel—ovarian cancer	0.000947	0.00285	CcSEcCtD
Carbinoxamine—Fatigue—Paclitaxel—ovarian cancer	0.00094	0.00283	CcSEcCtD
Carbinoxamine—Pollakiuria—Doxorubicin—ovarian cancer	0.000937	0.00282	CcSEcCtD
Carbinoxamine—Constipation—Paclitaxel—ovarian cancer	0.000932	0.00281	CcSEcCtD
Carbinoxamine—Confusional state—Docetaxel—ovarian cancer	0.000931	0.00281	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000925	0.00279	CcSEcCtD
Carbinoxamine—Agranulocytosis—Epirubicin—ovarian cancer	0.000912	0.00275	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Docetaxel—ovarian cancer	0.000905	0.00272	CcSEcCtD
Carbinoxamine—Drowsiness—Doxorubicin—ovarian cancer	0.000904	0.00272	CcSEcCtD
Carbinoxamine—Tachycardia—Docetaxel—ovarian cancer	0.000902	0.00272	CcSEcCtD
Carbinoxamine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000898	0.00271	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000886	0.00267	CcSEcCtD
Carbinoxamine—Anorexia—Docetaxel—ovarian cancer	0.000881	0.00265	CcSEcCtD
Carbinoxamine—Urticaria—Paclitaxel—ovarian cancer	0.000866	0.00261	CcSEcCtD
Carbinoxamine—Hypotension—Docetaxel—ovarian cancer	0.000863	0.0026	CcSEcCtD
Carbinoxamine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000844	0.00254	CcSEcCtD
Carbinoxamine—Insomnia—Docetaxel—ovarian cancer	0.000836	0.00252	CcSEcCtD
Carbinoxamine—Paraesthesia—Docetaxel—ovarian cancer	0.00083	0.0025	CcSEcCtD
Carbinoxamine—Somnolence—Docetaxel—ovarian cancer	0.000821	0.00247	CcSEcCtD
Carbinoxamine—Tinnitus—Epirubicin—ovarian cancer	0.000818	0.00246	CcSEcCtD
Carbinoxamine—Dyspepsia—Docetaxel—ovarian cancer	0.000813	0.00245	CcSEcCtD
Carbinoxamine—Decreased appetite—Docetaxel—ovarian cancer	0.000803	0.00242	CcSEcCtD
Carbinoxamine—Fatigue—Docetaxel—ovarian cancer	0.000796	0.0024	CcSEcCtD
Carbinoxamine—Constipation—Docetaxel—ovarian cancer	0.00079	0.00238	CcSEcCtD
Carbinoxamine—Chills—Epirubicin—ovarian cancer	0.000787	0.00237	CcSEcCtD
Carbinoxamine—Asthenia—Paclitaxel—ovarian cancer	0.000782	0.00236	CcSEcCtD
Carbinoxamine—Feeling abnormal—Docetaxel—ovarian cancer	0.000761	0.00229	CcSEcCtD
Carbinoxamine—Tinnitus—Doxorubicin—ovarian cancer	0.000757	0.00228	CcSEcCtD
Carbinoxamine—Tension—Epirubicin—ovarian cancer	0.000749	0.00226	CcSEcCtD
Carbinoxamine—Diarrhoea—Paclitaxel—ovarian cancer	0.000746	0.00225	CcSEcCtD
Carbinoxamine—Nervousness—Epirubicin—ovarian cancer	0.000742	0.00223	CcSEcCtD
Carbinoxamine—Chills—Doxorubicin—ovarian cancer	0.000728	0.00219	CcSEcCtD
Carbinoxamine—Dizziness—Paclitaxel—ovarian cancer	0.000721	0.00217	CcSEcCtD
Carbinoxamine—Vision blurred—Epirubicin—ovarian cancer	0.00072	0.00217	CcSEcCtD
Carbinoxamine—Agitation—Epirubicin—ovarian cancer	0.000702	0.00211	CcSEcCtD
Carbinoxamine—Tension—Doxorubicin—ovarian cancer	0.000693	0.00209	CcSEcCtD
Carbinoxamine—Vomiting—Paclitaxel—ovarian cancer	0.000693	0.00209	CcSEcCtD
Carbinoxamine—Nervousness—Doxorubicin—ovarian cancer	0.000686	0.00207	CcSEcCtD
Carbinoxamine—Vertigo—Epirubicin—ovarian cancer	0.000686	0.00207	CcSEcCtD
Carbinoxamine—Headache—Paclitaxel—ovarian cancer	0.000683	0.00206	CcSEcCtD
Carbinoxamine—Palpitations—Epirubicin—ovarian cancer	0.000675	0.00203	CcSEcCtD
Carbinoxamine—Vision blurred—Doxorubicin—ovarian cancer	0.000666	0.00201	CcSEcCtD
Carbinoxamine—Asthenia—Docetaxel—ovarian cancer	0.000663	0.002	CcSEcCtD
Carbinoxamine—Convulsion—Epirubicin—ovarian cancer	0.000662	0.00199	CcSEcCtD
Carbinoxamine—Agitation—Doxorubicin—ovarian cancer	0.000649	0.00196	CcSEcCtD
Carbinoxamine—Nausea—Paclitaxel—ovarian cancer	0.000647	0.00195	CcSEcCtD
Carbinoxamine—Vertigo—Doxorubicin—ovarian cancer	0.000635	0.00191	CcSEcCtD
Carbinoxamine—Diarrhoea—Docetaxel—ovarian cancer	0.000632	0.0019	CcSEcCtD
Carbinoxamine—Confusional state—Epirubicin—ovarian cancer	0.000628	0.00189	CcSEcCtD
Carbinoxamine—Palpitations—Doxorubicin—ovarian cancer	0.000624	0.00188	CcSEcCtD
Carbinoxamine—Convulsion—Doxorubicin—ovarian cancer	0.000612	0.00184	CcSEcCtD
Carbinoxamine—Dizziness—Docetaxel—ovarian cancer	0.000611	0.00184	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Epirubicin—ovarian cancer	0.00061	0.00184	CcSEcCtD
Carbinoxamine—Tachycardia—Epirubicin—ovarian cancer	0.000608	0.00183	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000602	0.00181	CcSEcCtD
Carbinoxamine—Anorexia—Epirubicin—ovarian cancer	0.000594	0.00179	CcSEcCtD
Carbinoxamine—Vomiting—Docetaxel—ovarian cancer	0.000587	0.00177	CcSEcCtD
Carbinoxamine—Hypotension—Epirubicin—ovarian cancer	0.000582	0.00175	CcSEcCtD
Carbinoxamine—Confusional state—Doxorubicin—ovarian cancer	0.000581	0.00175	CcSEcCtD
Carbinoxamine—Headache—Docetaxel—ovarian cancer	0.000579	0.00174	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000565	0.0017	CcSEcCtD
Carbinoxamine—Insomnia—Epirubicin—ovarian cancer	0.000564	0.0017	CcSEcCtD
Carbinoxamine—Tachycardia—Doxorubicin—ovarian cancer	0.000563	0.0017	CcSEcCtD
Carbinoxamine—Paraesthesia—Epirubicin—ovarian cancer	0.00056	0.00169	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000557	0.00168	CcSEcCtD
Carbinoxamine—Somnolence—Epirubicin—ovarian cancer	0.000554	0.00167	CcSEcCtD
Carbinoxamine—Anorexia—Doxorubicin—ovarian cancer	0.00055	0.00166	CcSEcCtD
Carbinoxamine—Nausea—Docetaxel—ovarian cancer	0.000549	0.00165	CcSEcCtD
Carbinoxamine—Dyspepsia—Epirubicin—ovarian cancer	0.000548	0.00165	CcSEcCtD
Carbinoxamine—Decreased appetite—Epirubicin—ovarian cancer	0.000542	0.00163	CcSEcCtD
Carbinoxamine—Hypotension—Doxorubicin—ovarian cancer	0.000539	0.00162	CcSEcCtD
Carbinoxamine—Fatigue—Epirubicin—ovarian cancer	0.000537	0.00162	CcSEcCtD
Carbinoxamine—Constipation—Epirubicin—ovarian cancer	0.000533	0.00161	CcSEcCtD
Carbinoxamine—Insomnia—Doxorubicin—ovarian cancer	0.000521	0.00157	CcSEcCtD
Carbinoxamine—Paraesthesia—Doxorubicin—ovarian cancer	0.000518	0.00156	CcSEcCtD
Carbinoxamine—Feeling abnormal—Epirubicin—ovarian cancer	0.000513	0.00155	CcSEcCtD
Carbinoxamine—Somnolence—Doxorubicin—ovarian cancer	0.000513	0.00154	CcSEcCtD
Carbinoxamine—Dyspepsia—Doxorubicin—ovarian cancer	0.000508	0.00153	CcSEcCtD
Carbinoxamine—Decreased appetite—Doxorubicin—ovarian cancer	0.000501	0.00151	CcSEcCtD
Carbinoxamine—Fatigue—Doxorubicin—ovarian cancer	0.000497	0.0015	CcSEcCtD
Carbinoxamine—Urticaria—Epirubicin—ovarian cancer	0.000495	0.00149	CcSEcCtD
Carbinoxamine—Constipation—Doxorubicin—ovarian cancer	0.000493	0.00149	CcSEcCtD
Carbinoxamine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000475	0.00143	CcSEcCtD
Carbinoxamine—Urticaria—Doxorubicin—ovarian cancer	0.000458	0.00138	CcSEcCtD
Carbinoxamine—Asthenia—Epirubicin—ovarian cancer	0.000447	0.00135	CcSEcCtD
Carbinoxamine—Diarrhoea—Epirubicin—ovarian cancer	0.000426	0.00128	CcSEcCtD
Carbinoxamine—Asthenia—Doxorubicin—ovarian cancer	0.000414	0.00125	CcSEcCtD
Carbinoxamine—Dizziness—Epirubicin—ovarian cancer	0.000412	0.00124	CcSEcCtD
Carbinoxamine—Vomiting—Epirubicin—ovarian cancer	0.000396	0.00119	CcSEcCtD
Carbinoxamine—Diarrhoea—Doxorubicin—ovarian cancer	0.000394	0.00119	CcSEcCtD
Carbinoxamine—Headache—Epirubicin—ovarian cancer	0.00039	0.00118	CcSEcCtD
Carbinoxamine—Dizziness—Doxorubicin—ovarian cancer	0.000381	0.00115	CcSEcCtD
Carbinoxamine—Nausea—Epirubicin—ovarian cancer	0.00037	0.00111	CcSEcCtD
Carbinoxamine—Vomiting—Doxorubicin—ovarian cancer	0.000367	0.0011	CcSEcCtD
Carbinoxamine—Headache—Doxorubicin—ovarian cancer	0.000361	0.00109	CcSEcCtD
Carbinoxamine—Nausea—Doxorubicin—ovarian cancer	0.000342	0.00103	CcSEcCtD
